Global Blood Therapeutics IncGBT rose 16.6 percent to $20.70 in the pre-market trading following a pair of news items announced in a company press release. The company has reached an agreement with the FDA regarding the design of its pivotal trial for GBT440 in adults and adolescents with sickle cell disease. The company announced in an SEC filing that the company's Chief Medical Officer, Eleanor Ramos, will retire, effective today.
Procter & Gamble CoPG shares rose 2.6 percent to $86.25 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
Under Armour IncUA rose 2.2 percent to $38.75 in pre-market trading after the company delivered higher than expected earnings and revenue for the third quarter. The company reiterated its revenue and operating income forecast for the year 2016.
Buckeye Partners, L.P.BPL shares fell 5.2 percent to $67.00 in the pre-market trading session. Buckeye Partners reported Q3 earnings of $1.19 per share on revenue of $766.6 million and announced plans to offer 7.5 million limited partnership units. Buckeye Partners also agreed to acquire 50 percent interest in VTTI B.V.'s global marine terminal business for $1.15 billion.